Phase Dual escalation 3 Weeks 21-24 Tirzepatide 12.5 mg/week Cagrilintide 1.7 mg/week Notes Approach maintenance
Z79.84 for long-term oral hypoglycemic use Drug-Induced Obesity (E66.1) Medications that commonly cause iatrogenic weight gain include: antipsychotics (olanzapine, clozapine, quetiapine), corticosteroids (E66.1 + adverse effect T code), insulin, certain antidepressants (tricyclics, mirtazapine), valproic acid, and lithium
They are intended to address specific gaps, such as meeting individual patient requirements or providing access during a verified drug shortage
Stay Hydrated: Alcohol can exacerbate dehydration, which may intensify side effects of Semaglutide
Compounded medications are not FDA-approved or reviewed before marketing for safety, effectiveness or quality
How to Use: Take one packet daily, preferably with a meal